Vitamina C plasmática está negativamente associada com a atividade das aminotransferases em pacientes com hepatite C não tratados
Ano de defesa: | 2007 |
---|---|
Autor(a) principal: | |
Orientador(a): | |
Banca de defesa: | |
Tipo de documento: | Dissertação |
Tipo de acesso: | Acesso aberto |
Idioma: | por |
Instituição de defesa: |
Universidade Federal de Santa Maria
BR Bioquímica UFSM Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica |
Programa de Pós-Graduação: |
Não Informado pela instituição
|
Departamento: |
Não Informado pela instituição
|
País: |
Não Informado pela instituição
|
Palavras-chave em Português: | |
Link de acesso: | http://repositorio.ufsm.br/handle/1/11158 |
Resumo: | In this study, the possible relationship between aminotransferase activities and markers of oxidative stress in hepatitis C patients was evaluated. Patients with HCV (hepatitis C virus) infection confirmed by positive HCV RNA in serum, without treatment to hepatitis C were divided into three groups: group I (15 to 39 U/L); group II (41 to 76 U/L); group III (81 to 311 U/L) of alanine aminotransferase (ALT) activity. A number of parameters were examined in blood as indicators of oxidative stress, including catalase, gluthatione peroxidase, thiobarbituric acid-reactive species (TBARS), non-protein thiol groups (NP-SH), protein thiol groups (P-SH) and vitamin C. The results demonstrated that markers of oxidative stress NP-SH, P-SH, TBARS, glutathione peroxidase and catalase activities measured in blood of these study groups were not significantly differents (P>0.05). The antioxidant vitamin C was significantly decreased in Group III (P=0.001) and Group II (P=0.03) when compared with Group I. The vitamin C level correlated negatively with AST activity (r=-0.29, P=0.042) for all patients. Our data suggested that vitamin C in plasma determination could be an additional indicator of hepatitis C severity, since plasma vitamin C was negatively associated with aminotransferase activities. Antioxidant therapy, such as vitamin C, may therefore have a role in retarded disease progression in liver |